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Ectodermal markers Merge Figure S2 . Immunochemistry of mesodermal and ectodermal markers. Cells on differentiation day 5 in the β differentiation were immunostained for mesodermal markers, Flk1, Pdgfra and CD31, and surface ectodermal markers, p63, CK14 and CK18. Scale bar indicates 100 m. The compounds were added to the β cell differentiation system of mouse ES cells during differentiation days 6-12 at 0.625 or 2.5 M. Twelve hit compounds showed > 1.5-fold increase in the number of β cells, defined as insulin-and GFP (Pdx1)-double positive. Microarray analysis was performed for cells treated on day 5 with MPA and harvested on day 6. The lists of up-and down-regulated genes after MPA treatment obtained from microarray analyses were imported in the Ingenuity Pathway analysis (IPA). Significance is expressed as P-values calculated using the right-tailed Fisher's exact test. Microarray analysis was performed for cells treated on day 5 with MPA and harvested on day 6. The lists of up-and down-regulated genes after MPA treatment obtained from microarray analyses were imported in the Ingenuity Pathway analysis (IPA). Significance is expressed as P-values calculated using the right-tailed Fisher's exact test. P-value ranges express the P-values for genes contained in each category. Fold changes in gene expression between MPA treatment and control analyzed in the microarray experiment are shown.
